Antibody

1,032개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs
AntibodyLimited DatastaleBiocon Biologics UK LtdPhase 3

Bmab1200 (Bmab1200)

Moderate to Severe Chronic Plaque Psoriasis · Moderate to Severe Chronic Plaque Psoria

#ModeratetoSevereChronicPlaquePso#Antibody#Phase3#monoclonal-antibody#Biocon
Trials 1Status Active
AntibodyLimited DatastaleBiocon Biologics UK PLCPhase 1

Bmab1800 (Bmab1800)

Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings) · Adult Patients With Stage IIB, IIC, and

#AdultPatientsWithStageIIBIICand#Antibody#Phase1#monoclonal-antibody#AdultPatientsWithStageIIB+3
Trials 1Status Recruiting
AntibodyLimited DatastaleBiocon Biologics UK PLCPhase 1

Bmab3000 (Bmab3000)

Healthy Male Participants · Healthy Male Participants

#HealthyMaleParticipants#Antibody#Phase1#monoclonal-antibody#Biocon
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity of California, San F…Phase 3

Bococizumab (Bococizumab)

Dyslipidemia; Cardiovascular Disease · Dyslipidemia

#Dyslipidemia#Antibody#Phase3#monoclonal-antibody#CardiovascularDisease+1
Trials 1Status Discontinued
AntibodyLimited DatastaleProvidence Health & ServicesPhase 2

Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG, Bortezomib, Thymoglobulin, Rituximab, Gamimune N,, Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG), Plasmapheresis)

Heart Transplantation · Heart Transplantation

#HeartTransplantation#Antibody#Phase2#monoclonal-antibody#Providence
Trials 1Status Discontinued
AntibodyLimited DatastaleAstraZenecaPhase 3

Brazikumab high dose (Brazikumab high dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#monoclonal-antibody#IBD+1
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 1

Brivanib + Cetuximab (Brivanib + Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleRadboud University Medical Cent…Approved

Brodalumab (Brodalumab)

Psoriasis; Psoriasis Vulgaris · Psoriasis

#Psoriasis#Antibody#Approved#monoclonal-antibody#PsoriasisVulgaris+1
Trials 1Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

cetuximab (C225, C225 (cetuximab))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#monoclonal-antibody#Sun
Trials 1Status Active
AntibodyLimited DatastaleNational Cancer Center, KoreaPhase 2

nivolumab (Opdivo, CA and Nivolumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#National
Trials 1Status Active
AntibodyLimited DatastaleGenzyme, a Sanofi CompanyPhase 2

alemtuzumab (CAMPATH, CAMPATH (alemtuzumab))

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#monoclonal-antibody#Genzyme
Trials 1Status Discontinued
AntibodyLimited DatastaleGerman Cancer Research CenterPhase 2

CC-1 and Toczilizumab (CC-1 and Toczilizumab)

Lung Cancer Squamous Cell · Lung Cancer Squamous Cell

#LungCancerSquamousCell#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Discontinued
AntibodyLimited DatastaleNantes University HospitalPreclinical

CEEP-RITUXIMAB (CEEP-RITUXIMAB)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Preclinical#monoclonal-antibody#Lymphoma+3
Trials 1Status Active
AntibodyLimited DatastaleProgen PharmaceuticalsPhase 1

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Cancer · Cancer

#Cancer#Antibody#Phase1#monoclonal-antibody#Progen
Trials 1Status Active
AntibodyLimited DatastaleTae Won KimPhase 2

durvalumab (Imfinzi, CKD-516 plus Durvalumab)

Colorectal Cancer; Solid Tumor · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#SolidTumor+1
Trials 1Status Discontinued
AntibodyLimited DatastaleInstitute of Hematology & Blood…Phase 2

CM336 Plus Isatuximab (CM336 Plus Isatuximab)

Multiple Myeloma (MM); Multiple Myeloma Light Chain Induced Renal Insufficiency · Multiple Myeloma (MM)

#MultipleMyelomaMM#Antibody#Phase2#monoclonal-antibody#MultipleMyelomaLightChainInduced+1
Trials 1Status Recruiting
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB007 (CMAB007)

Chronic Spontaneous Urticaria · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Recruiting
AntibodyLimited DatastaleShanghai Biomabs Pharmaceutical…Phase 3

CMAB008 (CMAB008)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB009 (CMAB009)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Active
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB015 (CMAB015)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Active

21 / 52 pages

← PreviousNext →